MAP1LC3A and malignant glioma: It was demonstrated that T-oligos could remarkably promote LC3-ll levels in malignant glioma cells and active autophagy by inhibiting mTOR and STAT3 signaling pathways, and then lead to the autophagic death of tumor cells [52].